Whole blood units are collected from subjects qualified in
accordance with current regulations and requirements for donors of
transfusible blood components, including screening with the Uniform
Donor History Questionnaire developed by the AABB and accepted by the
Food and Drug Administration for screening of donors of transfusible
Selection criteria may be adjusted at the request of the customer depending on the intended use of the product and the customer’s requirements, provided that subject safety requirements are met. At the customer’s request, subjects with a history of travel or medication ingestion that would preclude them from providing a blood product suitable for transfusion may provide whole blood for non-clinical and non-injectable uses.
We also offer qualification samples on potential subjects to allow the end-user to determine suitability for targeted materials. Specific subjects may be requested for product collection. Subjects may donate as often as once every eight weeks and up to six times in any 12-month period.
Subjects are usually prescreened prior to product collection for evidence of transmissible infectious diseases with the standard panel of tests used to screen blood products for transfusion acceptability. This panel of tests, with the exception of screening for exposure to T. cruzi, is usually repeated with each product collection.
Whole blood units are usually collected into a standard blood bag system used for collection of whole blood for transfusion and containing CPDA-1 or CP2D anticoagulant. Products collected in this manner contain approximately 500mL of whole blood.
Depending on the intended use of the collected product, whole blood may also be collected into a bag system containing sodium heparin. Products collected in this manner cannot be used for clinical research.
Specific subjects may be selected from our database based on:
- Blood type
- Human Erythrocyte Antigen genotype
Optional pre-collection qualification screening is available:
- Cell counts
- Anti-HLA Class I or Class II antibodies screen
- Recent medication usage
Optional post-collection release screening is available:
- Weight and/or volume
Packaging and ShipmentIn alignment with the intended use of the product and the customer’s requirements, whole blood units can be packaged and shipped on the date of collection for overnight delivery.
Products are packaged in a manner that ensures maintenance of a temperature between 1°C and 10°C during shipment. Continuous temperature monitoring data tracking devices are available for use at the customer’s request.